Cwm LLC Sells 967 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Cwm LLC reduced its position in HealthEquity, Inc. (NASDAQ:HQY) by 21.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,461 shares of the company’s stock after selling 967 shares during the period. Cwm LLC’s holdings in HealthEquity were worth $229,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Xponance Inc. boosted its stake in shares of HealthEquity by 1.2% in the 4th quarter. Xponance Inc. now owns 12,269 shares of the company’s stock worth $813,000 after buying an additional 147 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in HealthEquity by 11.9% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 18,926 shares of the company’s stock worth $1,255,000 after acquiring an additional 2,013 shares during the period. Mackenzie Financial Corp grew its position in shares of HealthEquity by 58.2% during the 4th quarter. Mackenzie Financial Corp now owns 1,807,407 shares of the company’s stock valued at $119,831,000 after acquiring an additional 664,979 shares during the period. Cornercap Investment Counsel Inc. increased its stake in shares of HealthEquity by 89.5% during the 4th quarter. Cornercap Investment Counsel Inc. now owns 17,193 shares of the company’s stock worth $1,140,000 after purchasing an additional 8,120 shares during the last quarter. Finally, Strs Ohio increased its stake in shares of HealthEquity by 49.1% during the 4th quarter. Strs Ohio now owns 16,100 shares of the company’s stock worth $1,067,000 after purchasing an additional 5,300 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

Insider Activity at HealthEquity

In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of the company’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total value of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Evelyn S. Dilsaver sold 32,500 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the transaction, the director now directly owns 32,123 shares in the company, valued at approximately $2,547,032.67. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Jon Kessler sold 33,765 shares of the firm’s stock in a transaction on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the sale, the chief executive officer now directly owns 126,635 shares in the company, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. In the last three months, insiders have sold 71,322 shares of company stock valued at $5,682,895. Corporate insiders own 2.70% of the company’s stock.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $78.55 on Friday. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43. The stock’s 50-day simple moving average is $80.81 and its two-hundred day simple moving average is $74.66. The firm has a market capitalization of $6.74 billion, a P/E ratio of 122.73, a P/E/G ratio of 1.30 and a beta of 0.55. HealthEquity, Inc. has a twelve month low of $48.86 and a twelve month high of $84.49.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Tuesday, March 19th. The company reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.42 by $0.08. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. The company had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. As a group, equities analysts anticipate that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on HQY shares. KeyCorp boosted their target price on HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, March 22nd. Royal Bank of Canada increased their target price on shares of HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 20th. BTIG Research upped their price target on shares of HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. Barrington Research reiterated an “outperform” rating and issued a $100.00 price objective on shares of HealthEquity in a research note on Friday, March 22nd. Finally, Bank of America increased their target price on HealthEquity from $93.00 to $97.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $96.17.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.